SAB Biotherapeutics Inc (SABS) — Free Cash Flow Generation Index
SAB Biotherapeutics Inc (SABS) has a Free Cash Flow Generation Index of 85.55x as of December 2022. Free cash flow of $18.54 Million represents 86% of operating cash flow ($216.72K). See SAB Biotherapeutics Inc (SABS) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SAB Biotherapeutics Inc Free Cash Flow Generation Index (2020–2021)
Historical FCF Generation Index trend for SAB Biotherapeutics Inc across 2 annual periods. Explore SABS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for SAB Biotherapeutics Inc (2020–2021)
Year-by-year Free Cash Flow Generation Index for SAB Biotherapeutics Inc. For the full company profile including market capitalisation, see market value of SAB Biotherapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | -4.51x | $-8.96 Million | $1.99 Million | $10.94 Million | ▼ -1553.9% |
| 2020 | -0.27x | $-2.73 Million | $10.00 Million | $12.73 Million | — |